Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children
This study is currently recruiting participants.
Verified November 2011 by West Virginia School of Osteopathic Medicine
Sponsor:
West Virginia School of Osteopathic Medicine
Information provided by (Responsible Party):
Kristie Bridges, West Virginia School of Osteopathic Medicine
ClinicalTrials.gov Identifier:
NCT01465789
First received: July 5, 2011
Last updated: November 4, 2011
Last verified: November 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to identify salivary biomarkers for monitoring cardiometabolic risk in children. The study hypothesis is that a combination of salivary biomarkers will predict the presence of risk factors including impaired fasting glucose, hypertension and dyslipidemia and will reflect changes in these risk factors over time.
| Condition |
|---|
|
Obesity Metabolic Syndrome |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in Children |
Resource links provided by NLM:
Further study details as provided by West Virginia School of Osteopathic Medicine:
Primary Outcome Measures:
- Correlation (R values) of salivary biomarkers with blood pressure percentile and serum glucose, HDL, total cholesterol, triglyceride and insulin levels in children [ Time Frame: Baseline ] [ Designated as safety issue: No ]
- Predictive utility (C-statistic) of salivary biomarkers for development of metabolic syndrome during childhood and adolescence [ Time Frame: final assessment at age 18 (up to 14 years depending on age of enrollment) ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
saliva
| Estimated Enrollment: | 40 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | December 2021 |
| Estimated Primary Completion Date: | December 2021 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 4 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Children participating in the CARDIAC Boot Camp program at the Robert C. Byrd Clinic in Lewisburg WV
Criteria
Inclusion Criteria:
- Participating in the CARDIAC Boot Camp Program
- Between the ages of 4 and 17
- Parental permission
- Ability to provide assent
Exclusion Criteria:
- Inability to comply with saliva collection procedures
- Renal insufficiency or juvenile gout
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01465789
Contacts
| Contact: Kristie G Bridges, PhD | 304-647-6223 | kbridges@osteo.wvsom.edu |
Locations
| United States, West Virginia | |
| West Virginia School of Osteopathic Medicine | Recruiting |
| Lewisburg, West Virginia, United States, 24901 | |
| Contact: Kristie Bridges, PhD 304-647-6223 kbridges@osteo.wvsom.edu | |
Sponsors and Collaborators
West Virginia School of Osteopathic Medicine
Investigators
| Principal Investigator: | Kristie G Bridges, PhD | West Virginia School of Osteopathic Medicine |
| Principal Investigator: | Jill Cochran, PhD, MSN, RN-C FNP | West Virginia School of Osteopathic Medicine |
More Information
No publications provided
| Responsible Party: | Kristie Bridges, Associate Professor, West Virginia School of Osteopathic Medicine |
| ClinicalTrials.gov Identifier: | NCT01465789 History of Changes |
| Other Study ID Numbers: | BCS 102.2 |
| Study First Received: | July 5, 2011 |
| Last Updated: | November 4, 2011 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Obesity Metabolic Syndrome X Overnutrition Nutrition Disorders Overweight Body Weight |
Signs and Symptoms Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013